comparemela.com

Latest Breaking News On - Adjupharm gmb - Page 12 : comparemela.com

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

/PRNewswire/ IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in.

Oren shusterAdjupharm gmbCanadian securities exchangeSource im cannabis corpIm cannabis corpNasdaq stock marketCompany contactProceedings of trichome financial corpPrnewswire im cannabis corpTrichome financial corpOrder of the ontario superior courtHerbs ltdNasdaq rulesListing ruleNotification letterNasdaq listing rule

IM Cannabis Corp: IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively

Israel generalOren shusterSde avrahamOranim pharmAdjupharm gmbVironna pharmPanaxia labs israel ltdOranim plus pharm ltdAcquisition corpPanaxia logistics ltdNutraceuticals incCanadian securities exchangeRosen high way ltdRa yarok pharm ltdPanaxia pharmaceutical industries israel ltdHerbs ltd

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

/PRNewswire/ IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced its financial.

Israel generalOranim pharmOren shusterSde avrahamAdjupharm gmbVironna pharmCompany contactCompany israeliMarketing ltdPanaxia logistics ltdIm cannabis corpTrichome financial corpPanaxia labs israel ltdHerbs ltdCanadian securities exchangeRosen high way ltd

IM Cannabis to Report Fourth Quarter & Full Year 2022 Financial Results on Wednesday, March 29 at 9:00am ET

/PRNewswire/ IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced that it will.

Adjupharm gmbOren shusterMaya lustigIm cannabis corpHerbs ltdAcquisition corpCompany contactSource im cannabis corpCompany canadianTrichome financial corpNutraceuticals incPrnewswire im cannabis corpFocus medical herbs ltdAdjupharm gmbhTrichome financialHighland grow

IM Cannabis Corp : IM Cannabis Announces Additional Restructuring Initiatives Designed to Drive Sustainable Profitability and Reduce Costs

The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings TORONTO and GLIL YAM, Israel

Dennis riedlRinat efrimaShai shemeshYael harroshOren shusterEyal fisherItay vagoAdjupharm gmbMarc lustigMaya lustigIm cannabis corpHerbs ltdOntario superior courtCompany israeliCompany contactAcquisition corp

vimarsana © 2020. All Rights Reserved.